Literature DB >> 9857890

Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation.

G Dangas1, R Mehran, P C Harpel, S K Sharma, S M Marcovina, G Dube, J A Ambrose, J T Fallon.   

Abstract

OBJECTIVES: The purpose of this study was the investigation of the in vivo role of lipoprotein(a) [Lp(a)] and inflammatory infiltrates in the human coronary atherosclerotic plaque and their correlation with the clinical syndrome of presentation.
BACKGROUND: Lipoprotein(a) is an atherogenic and thrombogenic lipoprotein, and has been implicated in the pathogenesis of acute coronary syndromes. Lipoprotein(a) induces monocyte chemoattraction and smooth muscle cell activation in vitro. Macrophage infiltration is considered one of the mechanisms of plaque rupture.
METHODS: This study of atherectomy specimens investigated the in vivo role of Lp(a) at different stages of the atherogenic process, and its relationship with macrophage infiltration. We examined coronary atheroma removed from 72 patients with stable or unstable angina. Specimens were stained with antibodies specific for Lp(a), macrophages (KP-1), and smooth muscle cells (alpha-actin). Morphometric analysis was used to quantify the plaque areas occupied by each of the three antigens, and their colocalization.
RESULTS: All specimens had localized Lp(a) staining; the mean fractional area was 58.2%. Ninety percent of the macrophage areas colocalized with Lp(a) positive areas, whereas 31.3% of the smooth muscle cell areas colocalized with Lp(a) positive areas. Patients with unstable angina (n = 46) had specimens with larger mean plaque Lp(a) areas than specimens from stable angina patients (n = 26): 64.4% versus 47.7% (p = 0.004). Unstable angina patients with rest pain (n = 28) had greater mean plaque Lp(a) area than unstable angina patients with crescendo exertional pain (n = 18): 71.1% versus 52.4% (p < 0.001). Mean KP-1 area was 31.2% in unstable rest angina versus 18.3% in stable angina (p = 0.05); alpha-actin area was greater in stable (48.5%) and crescendo exertional angina (48.8%) than in rest angina (30.4%). The strongest correlation between plaque KP-1 and Lp(a) area was in unstable rest angina (r = 0.88, p < 0.001), and between alpha-actin and Lp(a) areas in the crescendo exertional angina (r = 0.62, p < 0.01).
CONCLUSIONS: Lipoprotein(a) is ubiquitous in human coronary atheroma. It is detected in larger amounts in tissue from culprit lesions in patients with unstable compared to stable syndromes, and has significant colocalization with plaque macrophages. A correlation of plaque alpha-actin and Lp(a) area suggests a role of Lp(a) in plaque growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857890     DOI: 10.1016/s0735-1097(98)00469-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  24 in total

Review 1.  Lipoprotein(a) and coronary heart disease risk.

Authors:  S M Marcovina; R A Hegele; M L Koschinsky
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 2.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

3.  Relook at lipoprotein (A): independent risk factor of coronary artery disease in north Indian population.

Authors:  Jamal Yusuf; Neeraj Yadav; Saibal Mukhopadhyay; Abhishek Goyal; Vimal Mehta; Vijay Trehan; Sanjay Tyagi
Journal:  Indian Heart J       Date:  2014-04-21

4.  Abnormal lipoprotein(a) levels predict coronary artery calcification in Southeast Asians but not in Caucasians: use of noninvasive imaging for evaluation of an emerging risk factor.

Authors:  Abhinav Sharma; Manoefris Kasim; Parag H Joshi; Zhen Qian; Eric Krivitsky; Kamran Akram; Sarah Rinehart; Gustavo Vazquez; Joseph Miller; Mohammad Saifur Rohman; Szilard Voros
Journal:  J Cardiovasc Transl Res       Date:  2011-04-12       Impact factor: 4.132

5.  Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: A four-year follow-up.

Authors:  Jozo Boras; Spomenka Ljubic; Nikica Car; Zeljko Metelko; Mladen Petrovecki; Marijana Vucic Lovrencic; Zeljko Reiner
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

6.  Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke.

Authors:  Xiao-Wu Hong; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng; Wen-Jun Tu; Jing Yan
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

7.  Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options.

Authors:  Andreja Rehberger Likozar; Mark Zavrtanik; Miran Šebeštjen
Journal:  Ann Med       Date:  2020-06-08       Impact factor: 4.709

8.  Enigmatic role of lipoprotein(a) in cardiovascular disease.

Authors:  Erdembileg Anuurad; Byambaa Enkhmaa; Lars Berglund
Journal:  Clin Transl Sci       Date:  2010-12       Impact factor: 4.689

9.  The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population.

Authors:  Shao-yi Li; Yun Gao; Wei-ning Ma; Hua-chao Wang; Gang Zhou; Wen-chang Guo; Yun-hui Liu
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 10.  Inflammatory and thrombotic mechanisms in coronary atherosclerosis.

Authors:  D Tousoulis; G Davies; C Stefanadis; P Toutouzas; J A Ambrose
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.